• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Terminology used to describe ductal carcinoma in situ impacts patient preferences

bys25qthea
August 29, 2013
in Chronic Disease, Obstetrics, Oncology
Reading Time: 2 mins read
One-year of Herceptin preferable to two-year regimen
Share on FacebookShare on Twitter

Image: PD 

1. When the term cancer is used to describe ductal carcinoma in situ (DCIS), significantly more patients chose surgical management compared to medical management or active surveillance. 

2. If DCIS is described as a lesion or as abnormal cells, significantly more women chose active surveillance than medication or surgery. 

Evidence Rating Level: 3 (Average) 

Study Rundown: Ductal carcinoma in situ (DCIS) is a pre-cancerous lesion diagnosed in approximately 50,000 women yearly. Furthermore, despite the frequency at which it is diagnosed it only progresses to cancer in 1 out of every 5 women over the course of up to 40 years. It has been found that the terminology used to deliver the diagnoses to patients influences their treatment decisions. Women in this study were presented with 3 case scenarios that described a case of DCIS using the terms “noninvasive breast cancer”, “breast lesion” or “abnormal cells”.  They were given a number of treatment options with identical outcomes including surgery, medication or watchful waiting.  Significantly more women opted for surgery when the term “cancer” was used in the diagnosis compared to medical management or active surveillance whereas when the word “lesion” or “abnormal cells” were used, more women opted for active surveillance (p <.001). One drawback to this study was that the group of women was otherwise healthy and did not have a diagnosis of DCIS. Therefore, the reaction of women might have been more heavily influenced if they carried the diagnosis of DCIS. Overall, the study suggests that when the word cancer is avoided, there is a higher likelihood of women choosing active surveillance compared to surgery.

Click to read the study in JAMA Internal Medicine

RELATED REPORTS

Borderline-low hemoglobin levels linked to increased mortality

The Scan by 2 Minute Medicine®: Susie Wiles breast cancer diagnosis drives national screening surge, Jensen Huang’s GTC keynote turns healthcare AI into a pop-culture phenomenon, landmark ACSM guidelines simplify resistance training for longevity, and consumer alert issued for high-pressure cosmetic surgery chains

Replacing sedentary time with physical activity may lower risk of all-cause mortality

Relevant Reading: Ductal carcinoma in situ: terminology, classification, and natural history

In-Depth [randomized case-control study]: This study looked at the impact of terminology used for the description of ductal carcinoma in situ on the patient treatment preferences and included 394 women without a history of breast cancer. Three treatment options were given, surgery, medication or active surveillance all with the same outcomes. When the word “cancer” was used, 47% of the women opted for surgery compared to 20% for medication and 33% for active surveillance (p= <.001).  However if the word “cancer” was avoided and the word “lesion” or “abnormal cells” were used, 48% opted for active surveillance in both groups (p= <.001). Also, women with a history of non-breast cancer and higher socioeconomic status were more likely to choose surgery.

By Camellia Banerjee and Brittany Hasty

More from this author: Increased risk of hospitalization following the release of inmates, Early-onset dementia strongly correlated with alcohol intoxication in men 

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: cancerDCIS
Previous Post

Angiotensin-receptor blockers in diabetic nephropathy [Classics Series]

Next Post

Fluconazole in first trimester not associated with increase in most birth defects

RelatedReports

Cardiology

Borderline-low hemoglobin levels linked to increased mortality

September 14, 2026
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Artificial Intelligence

The Scan by 2 Minute Medicine®: Susie Wiles breast cancer diagnosis drives national screening surge, Jensen Huang’s GTC keynote turns healthcare AI into a pop-culture phenomenon, landmark ACSM guidelines simplify resistance training for longevity, and consumer alert issued for high-pressure cosmetic surgery chains

March 25, 2026
Reduced gestational weight gain with lifestyle intervention
Cardiology

Replacing sedentary time with physical activity may lower risk of all-cause mortality

March 2, 2026
Testosterone replacement in male cancer survivors helps improve body composition
Oncology

New model enhances prediction of prostate cancer-specific mortality

January 12, 2026
Next Post
Fluconazole in first trimester not associated with increase in most birth defects

Fluconazole in first trimester not associated with increase in most birth defects

Macitentan better than placebo for preventing progression of pulmonary arterial hypertension [SERAPHIN Trial]

Macitentan better than placebo for preventing progression of pulmonary arterial hypertension [SERAPHIN Trial]

Rituximab linked with reduced chronic immune disease following stem cell transplantation

Rituximab linked with reduced chronic immune disease following stem cell transplantation

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain
  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.